279 related articles for article (PubMed ID: 10805802)
1. AIS is an oncogene amplified in squamous cell carcinoma.
Hibi K; Trink B; Patturajan M; Westra WH; Caballero OL; Hill DE; Ratovitski EA; Jen J; Sidransky D
Proc Natl Acad Sci U S A; 2000 May; 97(10):5462-7. PubMed ID: 10805802
[TBL] [Abstract][Full Text] [Related]
2. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma.
Yamaguchi K; Wu L; Caballero OL; Hibi K; Trink B; Resto V; Cairns P; Okami K; Koch WM; Sidransky D; Jen J
Int J Cancer; 2000 Jun; 86(5):684-9. PubMed ID: 10797291
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S
Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
[TBL] [Abstract][Full Text] [Related]
5. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
6. Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients.
Yamaguchi K; Patturajan M; Trink B; Usadel H; Koch W; Jen J; Sidransky D
Int J Cancer; 2000 Nov; 89(6):524-8. PubMed ID: 11102898
[TBL] [Abstract][Full Text] [Related]
7. A second p53-related protein, p73L, with high homology to p73.
Senoo M; Seki N; Ohira M; Sugano S; Watanabe M; Inuzuka S; Okamoto T; Tachibana M; Tanaka T; Shinkai Y; Kato H
Biochem Biophys Res Commun; 1998 Jul; 248(3):603-7. PubMed ID: 9703973
[TBL] [Abstract][Full Text] [Related]
8. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities.
Senoo M; Matsumura Y; Habu S
Biochem Biophys Res Commun; 2001 Aug; 286(3):628-34. PubMed ID: 11511106
[TBL] [Abstract][Full Text] [Related]
10. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of p53, p63 and p73 protein and mRNA for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Int J Exp Pathol; 2004 Apr; 85(2):97-104. PubMed ID: 15154915
[TBL] [Abstract][Full Text] [Related]
12. Mutation and expression of the p51 gene in human lung cancer.
Tani M; Shimizu K; Kawahara C; Kohno T; Ishimoto O; Ikawa S; Yokota J
Neoplasia; 1999 Apr; 1(1):71-9. PubMed ID: 10935472
[TBL] [Abstract][Full Text] [Related]
13. Investigations for fine mapping of amplifications in chromosome 3q26.3-28 frequently occurring in squamous cell carcinomas of the head and neck.
Riazimand SH; Welkoborsky HJ; Bernauer HS; Jacob R; Mann WJ
Oncology; 2002; 63(4):385-92. PubMed ID: 12417794
[TBL] [Abstract][Full Text] [Related]
14. p63 and p73: life and death in squamous cell carcinoma.
Rocco JW; Ellisen LW
Cell Cycle; 2006 May; 5(9):936-40. PubMed ID: 16687923
[TBL] [Abstract][Full Text] [Related]
15. Role of p63 amplification and overexpression in lung cancer development.
Massion PP; Taflan PM; Rahman SM; Yildiz P; Shyr Y; Carbone DP; Gonzalez AL
Chest; 2004 May; 125(5 Suppl):102S. PubMed ID: 15136437
[No Abstract] [Full Text] [Related]
16. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
Hagiwara K; McMenamin MG; Miura K; Harris CC
Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
[TBL] [Abstract][Full Text] [Related]
18. Genetic instability of chromosome 3 in HPV-immortalized and tumorigenic human keratinocytes.
Montgomery KD; Tedford KL; McDougall JK
Genes Chromosomes Cancer; 1995 Oct; 14(2):97-105. PubMed ID: 8527399
[TBL] [Abstract][Full Text] [Related]
19. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
